Northern Trust’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$432K Hold
241,580
﹤0.01% 3667
2025
Q4
$541K Buy
241,580
+51,528
+27% +$136K ﹤0.01% 3630
2025
Q3
$460K Sell
190,052
-61,334
-24% -$163K ﹤0.01% 3678
2025
Q2
$149K Sell
251,386
-655,832
-72% -$511K ﹤0.01% 4020
2025
Q1
$795K Buy
907,218
+16,311
+2% +$22.6K ﹤0.01% 3379
2024
Q4
$1.51M Buy
890,907
+61,206
+7% +$110K ﹤0.01% 3174
2024
Q3
$1.59M Buy
829,701
+486,693
+142% +$1.1M ﹤0.01% 3134
2024
Q2
$844K Sell
343,008
-6,349
-2% -$17K ﹤0.01% 3316
2024
Q1
$573K Sell
349,357
-29,861
-8% -$43.9K ﹤0.01% 3521
2023
Q4
$675K Buy
379,218
+593
+0.2% +$1.27K ﹤0.01% 3443
2023
Q3
$1.73M Sell
378,625
-73,561
-16% -$704K ﹤0.01% 3022
2023
Q2
$5.06M Buy
452,186
+423,043
+1,452% +$4.5M ﹤0.01% 2492
2023
Q1
$330K Buy
29,143
+1,071
+4% +$11.4K ﹤0.01% 3624
2022
Q4
$193K Buy
28,072
+9,370
+50% +$89.5K ﹤0.01% 3889
2022
Q3
$169K Buy
+18,702
New +$163K ﹤0.01% 3941

Other funds holding PROK

Northern Trust's PROK Position: Q1 2026 in Review

Northern Trust held its ProKidney (PROK) position steady in Q1 2026 at 241,580 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #3667.

Northern Trust first reported a position in PROK in Q3 2022 and has held it in 15 quarters since. The position peaked at $5.06M in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Northern Trust held 241,580 shares of ProKidney worth $432K as of Q1 2026.
  • Northern Trust left its ProKidney share count unchanged in Q1 2026.
  • ProKidney made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3667 holding.
  • Northern Trust first reported a position in ProKidney in Q3 2022 and has held it in 15 quarters since.
  • Northern Trust's ProKidney position peaked at $5.06M in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.